SFM
BIOSU

Spartan Fund Management’s BioPlus Acquisition Corp. Unit BIOSU Stock Holding History

Spartan Fund Management’s Portfolio BIOSU Stock Details BIOSU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-150,000
Closed -$1.48M – 488
2022
Q2 		$1.48M Hold
150,000
– – 0.31% 148
2022
Q1 		$1.87M Buy
+150,000
New +$1.5M 0.31% 154

Other funds holding BIOSU

Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $5.53B AUM 25.79% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return

Spartan Fund Management's BIOSU Position: Q3 2022 in Review

Spartan Fund Management sold out of BioPlus Acquisition Corp. Unit (BIOSU) in Q3 2022, closing a stake of 150,000 shares — an estimated $1.48M sold.

Spartan Fund Management first reported a position in BIOSU in Q1 2022 and held it in 2 quarters. The position peaked at $1.87M in Q1 2022. 15 funds tracked by Wall St. Rank hold BIOSU as of Q3 2022.

  • Spartan Fund Management reported no remaining BioPlus Acquisition Corp. Unit position as of Q3 2022 after selling out during the quarter.
  • Spartan Fund Management sold 150,000 BioPlus Acquisition Corp. Unit shares in Q3 2022, an estimated $1.48M.
  • Spartan Fund Management first reported a position in BioPlus Acquisition Corp. Unit in Q1 2022 and held it in 2 quarters.
  • Spartan Fund Management's BioPlus Acquisition Corp. Unit position peaked at $1.87M in Q1 2022.
  • 15 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Unit as of Q3 2022.

Based on Spartan Fund Management's 13F filing for Q3 2022, filed 26 Oct 2022.